Indications And Dose
Breast cancer in postmenopausal women ▶BY MOUTH ▶Adult: 10–20 mg daily Prostate cancer ▶BY MOUTH ▶Adult: 1–3 mg daily
PDF page 1022
Loading InternPractice…
Drug reference
Breast cancer in postmenopausal women ▶BY MOUTH ▶Adult: 10–20 mg daily Prostate cancer ▶BY MOUTH ▶Adult: 1–3 mg daily
PDF page 1022
Cardiovascular disease
PDF page 1022
Bone pain (in breast cancer). breast abnormalities. cervical mucus increased. cholelithiasis. contact lens intolerance. depression. erectile dysfunction . erythema nodosum. feminisation. fluid retention. gynaecomastia. headaches. hypercalcaemia (in breast cancer). hypertension. increased risk of thrombosis. jaundice cholestatic. mood altered. nausea. neoplasms. skin reactions. sodium retention. testicular atrophy. uterine disorders. vomiting. weight changes. withdrawal bleed
PDF page 1022
In first trimester, high doses associated with vaginal carcinoma, urogenital abnormalities, and reduced fertility in female offspring. Increased risk of hypospadias in male offspring.
PDF page 1022
Manufacturer advises caution in mild to moderate impairment; avoid in severe or active impairment.
PDF page 1022
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Diethylstilbestrol (Non-proprietary) Diethylstilbestrol 1 mg Diethylstilbestrol 1mg tablets | 28 tablet P £115.68 DT = £115.57 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES › ANTI-GONADOTROPHIN- RELEASING HORMONES
PDF page 1022
10–20 mg daily
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1022
1–3 mg daily
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1022